ABEONA THERAPEUTICS INC (ABEO:NASDAQ)
$4.91 -0.21 (-4.1016%)
Analysed ABEONA THERAPEUTICS INC (ABEO:NASDAQ) News Sources
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors
07-04-2026
yahoo.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06-04-2026
yahoo.com
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York
02-04-2026
yahoo.com
Abeona Therapeutics Inc. Q4 2025 Earnings Call Summary
20-03-2026
moby.co
ABEO: Momentum Building for Zevaskyn®
18-03-2026
yahoo.com
Abeona Therapeutics Inc (ABEO) Q4 2025 Earnings Call Highlights: Strong Demand for Zivasskin ...
17-03-2026
yahoo.com
Abeona Therapeutics Q4 Earnings Call Highlights
17-03-2026
marketbeat.com
Abeona (ABEO) Q4 2025 Earnings Call Transcript
17-03-2026
fool.com
Abeona Therapeutics: Q4 Earnings Snapshot
17-03-2026
yahoo.com
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
17-03-2026
yahoo.com
What is the current price of ABEONA THERAPEUTICS INC (ABEO:NASDAQ)?
The current price of ABEONA THERAPEUTICS INC (ABEO:NASDAQ) is $4.91.
ABEONA THERAPEUTICS INC (ABEO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ABEONA THERAPEUTICS INC (ABEO:NASDAQ) since the previous trading day is $-0.21.
ABEONA THERAPEUTICS INC (ABEO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ABEONA THERAPEUTICS INC (ABEO:NASDAQ) since the previous trading day is -4.1016%.
What is the most recent average sentiment score for ABEONA THERAPEUTICS INC (ABEO:NASDAQ)?
The most recent average sentiment score for ABEONA THERAPEUTICS INC (ABEO:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for ABEONA THERAPEUTICS INC (ABEO:NASDAQ)?
The most recent sentiment for ABEONA THERAPEUTICS INC (ABEO:NASDAQ) is .
SEC-8K** Filing Available For ABEONA THERAPEUTICS INC (ABEO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.